Literature DB >> 10377161

Chlamydial colonization of multiple mucosae following infection by any mucosal route.

L L Perry1, S Hughes.   

Abstract

Chlamydia trachomatis inoculated by any mucosal route colonized multiple murine mucosae and, in most cases, the spleen, liver, and kidneys. Cell-to-cell transmission, systemic dissemination, and autoinoculation of infectious fluids may have contributed to chlamydial spread. Intermucosal trafficking of protective T cells cannot be accurately evaluated by using live chlamydial challenges.

Entities:  

Mesh:

Year:  1999        PMID: 10377161      PMCID: PMC116566     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  34 in total

1.  Heterotypic protection of mice against chlamydial salpingitis and colonization of the lower genital tract with a human serovar F isolate of Chlamydia trachomatis by prior immunization with recombinant serovar L1 major outer-membrane protein.

Authors:  M Tuffrey; F Alexander; W Conlan; C Woods; M Ward
Journal:  J Gen Microbiol       Date:  1992-08

2.  Immunoprophylaxis of Chlamydia trachomatis lymphogranuloma venereum pneumonitis in mice by oral immunization.

Authors:  Z D Cui; L J LaScolea; J Fisher; P L Ogra
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

3.  Oral immunization with chlamydial major outer membrane protein (MOMP).

Authors:  H R Taylor; J Whittum-Hudson; J Schachter; H D Caldwell; R A Prendergast
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-12       Impact factor: 4.799

Review 4.  The common mucosal immune system and current strategies for induction of immune responses in external secretions.

Authors:  J Mestecky
Journal:  J Clin Immunol       Date:  1987-07       Impact factor: 8.317

5.  Extraocular infections in children in areas with endemic trachoma.

Authors:  R Malaty; S Zaki; M E Said; D W Vastine; D W Dawson; J Schachter
Journal:  J Infect Dis       Date:  1981-06       Impact factor: 5.226

6.  Histopathology of Chlamydia trachomatis salpingitis after primary and repeated reinfections in the monkey subcutaneous pocket model.

Authors:  D L Patton; C C Kuo
Journal:  J Reprod Fertil       Date:  1989-03

7.  Is trachoma an ocular component of a more generalised chlamydial infection?

Authors:  J Schachter; C R Dawson
Journal:  Lancet       Date:  1979-03-31       Impact factor: 79.321

8.  Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis.

Authors:  H D Caldwell; J Kromhout; J Schachter
Journal:  Infect Immun       Date:  1981-03       Impact factor: 3.441

9.  Experimental Chlamydia trachomatis salpingitis in mice: initial studies on the characterization of the leukocyte response to chlamydial infection.

Authors:  D L Patton; D V Landers; J Schachter
Journal:  J Infect Dis       Date:  1989-06       Impact factor: 5.226

10.  Role of cell-mediated immunity in chlamydial infection: implications for ocular immunity.

Authors:  D M Williams; J Schachter
Journal:  Rev Infect Dis       Date:  1985 Nov-Dec
View more
  40 in total

Review 1.  Immunological basis of Chlamydia induced reactive arthritis.

Authors:  J S Gaston
Journal:  Sex Transm Infect       Date:  2000-06       Impact factor: 3.519

2.  Antigen-Specific CD4+ T Cell-Derived Gamma Interferon Is Both Necessary and Sufficient for Clearing Chlamydia from the Small Intestine but Not the Large Intestine.

Authors:  Hui Lin; Conghui He; John J Koprivsek; Jianlin Chen; Zhiguang Zhou; Bernard Arulanandam; Zhenming Xu; Lingli Tang; Guangming Zhong
Journal:  Infect Immun       Date:  2019-05-21       Impact factor: 3.441

3.  Gastrointestinal Coinfection Promotes Chlamydial Pathogenicity in the Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Al-Mutassim Hani Abu-Khdeir; Zhi Huo; Xin Sun; Nu Zhang; Robert Schenken; Yufeng Wang; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2020-03-23       Impact factor: 3.441

4.  The Cryptic Plasmid Improves Chlamydia Fitness in Different Regions of the Gastrointestinal Tract.

Authors:  Jingyue Ma; Conghui He; Zhi Huo; Ying Xu; Bernard Arulanandam; Quanzhong Liu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-02-20       Impact factor: 3.441

5.  Intravenous Inoculation with Chlamydia muridarum Leads to a Long-Lasting Infection Restricted to the Gastrointestinal Tract.

Authors:  Jin Dai; Tianyuan Zhang; Luying Wang; Lili Shao; Cuiming Zhu; Yuyang Zhang; Courtney Failor; Robert Schenken; Joel Baseman; Cheng He; Guangming Zhong
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

6.  Nonpathogenic Colonization with Chlamydia in the Gastrointestinal Tract as Oral Vaccination for Inducing Transmucosal Protection.

Authors:  Luying Wang; Cuiming Zhu; Tianyuan Zhang; Qi Tian; Nu Zhang; Sandra Morrison; Richard Morrison; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2018-01-22       Impact factor: 3.441

7.  A Macaque Model for Rectal Lymphogranuloma Venereum and Non-Lymphogranuloma Venereum Chlamydia trachomatis: Impact on Rectal Simian/Human Immunodeficiency Virus Acquisition.

Authors:  Sundaram Ajay Vishwanathan; Rachael D Aubert; Monica R Morris; Chunxia Zhao; Christi Philips; George M Khalil; Frank Deyounks; Kristen Kelley; Jana M Ritter; C Y Chen; Ellen N Kersh; Janet M McNicholl
Journal:  Sex Transm Dis       Date:  2017-09       Impact factor: 2.830

8.  The Plasmid-Encoded pGP3 Promotes Chlamydia Evasion of Acidic Barriers in Both Stomach and Vagina.

Authors:  Tianyuan Zhang; Zhi Huo; Jingyue Ma; Cheng He; Guangming Zhong
Journal:  Infect Immun       Date:  2019-04-23       Impact factor: 3.441

9.  Effects of Immunomodulatory Drug Fingolimod (FTY720) on Chlamydia Dissemination and Pathogenesis.

Authors:  Zengzi Zhou; Lingxiang Xie; Luying Wang; Min Xue; Dabao Xu; Guangming Zhong
Journal:  Infect Immun       Date:  2020-10-19       Impact factor: 3.441

Review 10.  Hidden in plain sight: chlamydial gastrointestinal infection and its relevance to persistence in human genital infection.

Authors:  Roger G Rank; Laxmi Yeruva
Journal:  Infect Immun       Date:  2014-01-13       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.